Environmental Remediation & CleanTech / Advanced Medical Technologies
Strategic Profile
BioLargo differentiates through proprietary technologies like its Aqueous Electrostatic Concentrator (AEC) for PFAS treatment and Clyrasept™ for advanced wound care. The company is transitioning toward commercialization and revenue generation, with recent municipal water system installations and clinical validation of medical products positioning it at the intersection of environmental and life sciences innovation.
Cyborg Score Rationale
BioLargo operates in high-demand environmental and medical sectors with differentiated technology, but remains pre-profitability with minimal revenue ($17.8M trailing twelve months). The micro-cap valuation (~$73.7M) and OTC trading reflect high execution risk, though recent commercialization milestones and clinical validations demonstrate progress toward viability.
Top Insights
PFAS water contamination represents massive market opportunity as regulatory pressure intensifies; AEC technology addresses municipalities directly
Clyra Medical ViaCLYR™ showed positive clinical results in February 2026, advancing toward broader commercial adoption
Multi-segment revenue model reduces concentration risk but complicates execution; five-subsidiary structure enables focused expertise
Early-stage profitability path unclear; company requires successful commercial scaling to justify equity valuation
Named Competitors
Advanced Water Treatment — Larger water treatment solutions provider
Water Treatment Technologies — Public competitor in water treatment space
Odor and VOC Control — Competitor in industrial water and environmental treatment
Recent Developments
(February 2026) ViaCLYR clinical experience presented at Boswick Symposium showing rapid wound transformation and antimicrobial performance
(February 2026) Initial distribution launch for advanced wound irrigation solution marking transition to revenue-generating operations
(January 2026) AEC PFAS treatment system installed at Lake Stockholm municipal water facility in New Jersey
Open the full interactive BioLargo, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.